Author/Authors :
Jalalian, Mehrdad Khorasan-e Razavi Blood Center - Research Center of Iranian Blood Transfusion Organization - Department of Research, ايران , Jalalian, Mehrdad Universiti Putra Malaysia - Faculty of Medicine and Health Sciences - Department of Community Health, Malaysia , Latiff, Latiffah Universiti Putra Malaysia - Faculty of Medicine and Health Sciences - Department of Community Health, Malaysia , Niazmand, Saeed mashhad university of medical sciences - School of Medicine - Department of Physiology, مشهد, ايران , Hanachi, Parichehr alzahra university - Women Research Center - Department of Biomedical, تهران, ايران , Seyed Hassan, Tajuddin Universiti Putra Malaysia - Faculty of Medicine and Health Sciences - Department of Community Health, Malaysia
Abstract :
Majlessi and colleagues recently reported an analysis on adverse reactions to blood donation, one of the most significant current discussions in blood safety (1). Strategies to manage, prevent or decrease the frequency of adverse reactions to blood donation are among the key measures in donor recruitment programs. Similar studies have shown that up to 36% of donors may experience at least one of the adverse effects of blood donation (2). The following consists of our comments on Tehran study. The main reason to write this critique is the opportunity to review a challenging issue in blood donor safety.
